Rapamycin was shown to affect neuroinflammation by influencing autophagy and growing regulatory T cells, two key components in the pathophysiology of ALS. It raised the proportion of B cells and monocytes while lowering  IL-18 protein and mRNA relative expression of the pro-inflammatory cytokine IL-18. Here, IL18 is linked to amyotrophic lateral sclerosis.